中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A Pharmacogenomic Landscape in Human Liver Cancers

文献类型:期刊论文

作者Qiu, Zhixin13; Zhang, Zhengtao13; Li, Chun13; Wang, Chenhua13; Cen, Jin13; Chen, Xiaotao13; Shu, Yajing13; Zhang, Zhao13; Sun, Lulu13; Min, Lihua13
刊名CANCER CELL
出版日期2019
卷号36期号:2页码:179-+
ISSN号1535-6108
关键词association GSK-3 beta BDNF major depressive disorder venlafaxine
DOI10.1016/j.ccell.2019.07.001
文献子类Article
英文摘要Liver cancers are highly heterogeneous with poor prognosis and drug response. A better understanding between genetic alterations and drug responses would facilitate precision treatment for liver cancers. To characterize the landscape of pharmacogenomic interactions in liver cancers, we developed a protocol to establish human liver cancer cell models at a success rate of around 50% and generated the Liver Cancer Model Repository (LIMORE) with 81 cell models. LIMORE represented genomic and transcriptomic heterogeneity of primary cancers. Interrogation of the pharmacogenomic landscape of LIMORE discovered unexplored gene-drug associations, including synthetic lethalities to prevalent alterations in liver cancers. Moreover, predictive biomarker candidates were suggested for the selection of sorafenib-responding patients. LIMORE provides a rich resource facilitating drug discovery in liver cancers.
学科主题Oncology ; Cell Biology
WOS关键词HEPATITIS-B-VIRUS ; HEPATOCELLULAR-CARCINOMA ; ORGANOID CULTURES ; CELL-LINES ; MUTATIONAL LANDSCAPE ; LARGE-SCALE ; MODELS ; GENOME ; CATENIN ; SENSITIVITY
语种英语
出版者CELL PRESS
WOS记录号WOS:000480434200008
版本出版稿
源URL[http://202.127.25.144/handle/331004/528]  
专题中国科学院上海生命科学研究院营养科学研究所
作者单位1.Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China;
2.Chinese Acad Sci, Biores Innovat Ctr Suzhou, Shanghai Inst Biochem & Cell Biol, Suzhou 215121, Jiangsu, Peoples R China,
3.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China;
4.Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China;
5.Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing 211166, Jiangsu, Peoples R China;
6.Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA;
7.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 5, Shanghai 200438, Peoples R China;
8.Shanghai ChemPartner Co Ltd, Shanghai 201203, Peoples R China;
9.Nanjing Med Univ, Liver Transplantat Ctr, Key Lab Living Donor Liver Transplantat, Minist Publ Hlth,Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China;
10.Shanghai Jiao Tong Univ, SJTU Yale Joint Ctr Biostat, Dept Bioinformat & Biostat, Shanghai 200240, Peoples R China;
推荐引用方式
GB/T 7714
Qiu, Zhixin,Zhang, Zhengtao,Li, Chun,et al. A Pharmacogenomic Landscape in Human Liver Cancers[J]. CANCER CELL,2019,36(2):179-+.
APA Qiu, Zhixin.,Zhang, Zhengtao.,Li, Chun.,Wang, Chenhua.,Cen, Jin.,...&,.(2019).A Pharmacogenomic Landscape in Human Liver Cancers.CANCER CELL,36(2),179-+.
MLA Qiu, Zhixin,et al."A Pharmacogenomic Landscape in Human Liver Cancers".CANCER CELL 36.2(2019):179-+.

入库方式: OAI收割

来源:上海营养与健康研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。